Clinical Trials Directory

Trials / Completed

CompletedNCT01428024

Study to Evaluate Efficacy, Safety and Injection Technique of Restylane Lip Volume and Restylane Lip Refresh

An Open, Multi-center Study Evaluating Efficacy, Safety and Injection Technique of Restylane Lip Products for Lip Enhancement and Lip Rejuvenation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to demonstrate the efficacy and safety of two new Restylane Lip products, Restylane Lip Volume and Restylane Lip Refresh, and to collect information on the injection technique.

Detailed description

Restylane Lip Volume is intended to be used for lip enhancement and Restylane Lip Refresh is intended to restore hydrobalance and improve skin structure of the lips (referred to as lip rejuvenation in this protocol), respectively. The lidocaine content is designed to reduce the subject's pain during treatment. The objectives of this open, multicenter study are to evaluate efficacy and safety of the products for the studied indications and to collect information on injection techniques used.

Conditions

Interventions

TypeNameDescription
DEVICERestylane Lip VolumeTreatment of up to 1,5 ml product for upper and lower lip, respectively at week 0 and optional at week 12.
DEVICERestylane Lip RefreshTreatment of up to 0,5 ml product for upper and lower lip, respectively at week 0 and optional at week 12.

Timeline

Start date
2011-09-01
Primary completion
2011-11-01
Completion
2012-06-01
First posted
2011-09-02
Last updated
2022-08-26
Results posted
2018-10-18

Locations

3 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01428024. Inclusion in this directory is not an endorsement.